The WSJ writes about the sad story of Myriad Genetics, who paid $200,000 for a huge coming out party at a conference for their Alzheimer’s drug.
Trouble is, the drug didn’t work, so they’re left with an empty, fancy booth.
The WSJ writes about the sad story of Myriad Genetics, who paid $200,000 for a huge coming out party at a conference for their Alzheimer’s drug.
Trouble is, the drug didn’t work, so they’re left with an empty, fancy booth.
Get free updates delivered free to your inbox.
Comments are moderated before they are published. Please read the comment policy.